Blueprint Medicines (BPMC) Rises 68.2% in 3 Months: Here's Why

This article was originally published on Nasdaq

Shares of Blueprint Medicines Corporation BPMC have rallied 68.2% in the past three months compared with the industry’s rise of 10.2%.